Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
Indexed incrossrefpubmed
Abstract
BACKGROUND: Whether catheter ablation (CA) is superior to amiodarone (AMIO) for the treatment of persistent atrial fibrillation (AF) in patients with heart failure is unknown. METHODS AND RESULTS: This was an open-label, randomized, parallel-group, multicenter study. Patients with persistent AF, dual-chamber implantable cardioverter defibrillator or cardiac resynchronization therapy defibrillator, New York Heart Association II to III, and left ventricular ejection fraction
Citation impact
853
total citations
- FWCI
- 59.12
- Percentile
- 100%
- References
- 39
Citations per year
Authors
26Topics & keywords
Topics
Keywords
- Medicine
- Amiodarone
- Hazard ratio
- Atrial fibrillation
- Confidence interval
- Ejection fraction
- Cardiology
- Heart failure
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.